AcelRx Pharmaceuticals
Stock Forecast, Prediction & Price Target
AcelRx Pharmaceuticals Financial Estimates
AcelRx Pharmaceuticals Revenue Estimates
AcelRx Pharmaceuticals EBITDA Estimates
AcelRx Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $2.81M N/A | $1.77M -37.15% | $651K -63.24% | Avg: $2.50M Low: $1.20M High: $3.85M avg. 284.56% | |||
Net Income
% change YoY
| $-35.09M N/A | $47.75M 236.05% | $-10.28M -121.54% | Avg: $-22.24M Low: $-8.07M High: $-5.18M avg. -116.27% | |||
EBITDA
% change YoY
| $-30.83M N/A | $-30.18M 2.09% | $-16.88M 44.04% | Avg: $-2.50M Low: $-1.20M High: $-3.85M avg. 85.17% | |||
EPS
% change YoY
| -$5.86 N/A | $5.73 197.78% | -$0 -100.01% | Avg: -$0.9 Low: -$1.09 High: -$0.7 avg. -127757.14% | |||
Operating Expenses
% change YoY
| $35.03M N/A | $30.86M -11.88% | $17.54M -43.17% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is AcelRx Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -116.27% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is -8.07M, average is -22.24M and high is -5.18M.
What is AcelRx Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 284.56% in 2025-2025.
We have gathered data from 2 analysts. Their low revenue estimate is $1.20M, average is $2.50M and high is $3.85M.
What is AcelRx Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -127757.14% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.09, average is -$0.9 and high is $-0.7.